Cancer Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-10-11 ms7000001058021119

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿

19 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-10-11 ms6000001620765478

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-10-08 1469323em90暂无昵称

这个杂志under review一般多久? 临床型

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2021-09-22 门童

pending editor assignment一般要多久？

57 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-04-25 ms1000001855466861

审稿速度:6.0 | 投稿命中率:95.0
偏重的研究方向：筛查;肠癌;临床
经验分享：两投两中，大修后接收，投稿周期太长

53 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-05-16 道是也无风雨也无晴

审稿速度:2.0 | 投稿命中率:50.0
经验分享：终于接收了，编辑很好。不过过程也挺曲折的。

35 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-08-24 ms3000001702722814

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：生物信息学
经验分享：pending editor assignment 已经一个月了，你们呢？崩溃

31 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-09-06 LightFlash

审稿速度:6.0
经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-08-13 ltt6123

偏重的研究方向：肿瘤
经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭

21 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2093201, encodeId=2f20209320117, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：真的超级慢着急发文章的童鞋一定要慎重投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=187a5627355, createdName=ms7000001058021119, createdTime=Tue Oct 11 20:20:13 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093199, encodeId=6c04209319906, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：脑瘫审稿人大修三个审稿人修回去R3不知道去哪儿 R2只是要求补充原始数据被R1喷的体无完肤要求回答的问题之前也补充好了按照R1的要求那样设计实验感觉能投NC了建议审稿人去照照镜子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e92b5648931, createdName=ms6000001620765478, createdTime=Tue Oct 11 20:18:03 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092462, encodeId=49412092462ae, content=这个杂志under review一般多久? 临床型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74db5149632, createdName=1469323em90暂无昵称, createdTime=Sat Oct 08 11:17:58 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053759, encodeId=441f1053e590b, content=pending editor assignment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Wed Sep 22 13:08:22 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214233, encodeId=eebb12142331f, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：筛查;肠癌;临床 经验分享：两投两中，大修后接收，投稿周期太长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da895684430, createdName=ms1000001855466861, createdTime=Mon Apr 25 21:44:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220178, encodeId=38ac12201e892, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：终于接收了，编辑很好。不过过程也挺曲折的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96e75189440, createdName=道是也无风雨也无晴, createdTime=Mon May 16 23:59:27 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240735, encodeId=46651240e3553, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：生物信息学 经验分享：pending editor assignment 已经一个月了，你们呢？崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e98d8252002, createdName=ms3000001702722814, createdTime=Wed Aug 24 16:31:03 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247408, encodeId=e6ba124e4084e, content=审稿速度:6.0 经验分享：请问这个杂志需要几个审稿意见啊？已经投了半年了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a1b5456615, createdName=LightFlash, createdTime=Tue Sep 06 08:25:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238435, encodeId=66e0123843515, content=偏重的研究方向：肿瘤 经验分享：去年11月accept，至今仍未刊出，心塞，这是什么状况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ab323245, createdName=ltt6123, createdTime=Sat Aug 13 10:28:07 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235388, encodeId=64a9123538802, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床肿瘤研究 经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。 2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer 2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。 2022-06-17第一次返修，意见很中肯也很专业，3天修回 2022-07-19第二次返修 2022-07-20 pending recommedation 2022-07-22 pending decision 2022-07-28 Accepted 总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/19/1e82e9f2be68819f31e63084291d3da9.jpg, createdBy=1a192304652, createdName=等月光倾城, createdTime=Thu Jul 28 23:44:52 CST 2022, time=2022-07-28, status=1, ipAttribution=)]

2022-07-28 等月光倾城

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：临床肿瘤研究
经验分享：这个杂志速度看运气，有的人很快全程两个月就ok了，我的就慢得很，催稿邮件都写了五六次，感觉全程是在催着编辑干活一样。
2022-02-11投稿，然后格式审查两天后说重复率不合格（>10%）要求降重，于是查重后稍微改了一下就通过了。期间是漫长的等待分配编辑和编辑找reviewer
2022-03-25开始under review, 期间几次催稿，编辑回复很快也很友善，说很多拒绝审稿，所以耽误时间。
2022-06-17第一次返修，意见很中肯也很专业，3天修回
2022-07-19第二次返修
2022-07-20 pending recommedation
2022-07-22 pending decision
2022-07-28 Accepted
总的来说感觉只要文章还可以，能被送审，接收概率还挺高的。

36 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务